Mineralocorticoid receptor antagonists for primary aldosteronism-appropriate or not?

Eur J Endocrinol. 2023 Mar 2;188(3):lvad020. doi: 10.1093/ejendo/lvad020.

Oskar Ragnarsson^{1

2

3}, Per Dahlqvist⁴, Andreas Muth^{5

6}, Jan Calissendorff^{7

8}, Tommy Olsson⁴

¹ Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, SE-405 30 Gothenburg, Sweden.
² Department of Endocrinology, Sahlgrenska University Hospital, 413 45 Gothenburg, Sweden.
³ Wallenberg Centre for Molecular and Translational Medicine, University of Gothenburg, SE-405 30 Gothenburg, Sweden.
⁴ Department of Public Health and Clinical Medicine, Umeå University, SE-901 87 Umeå, Sweden.
⁵ Department of Surgery, Sahlgrenska University Hospital, 413 45 Gothenburg, Sweden.
⁶ Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, SE-405 30 Gothenburg, Sweden.
⁷ Department of Molecular Medicine and Surgery, Karolinska Institutet, SE-171 77 Stockholm, Sweden.
⁸ Department of Endocrinology, Karolinska University Hospital, SE-171 76 Stockholm, Sweden.

No abstract available

Keywords: adrenal vein sampling; adrenalectomy; mineralocorticoid receptor antagonist; primary aldosteronism.

Publication types